Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

3 terminated/withdrawn out of 24 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed trials have results

Key Signals

7 recruiting2 with results

Enrollment Performance

Analytics

N/A
11(84.6%)
Phase 3
1(7.7%)
Phase 4
1(7.7%)
13Total
N/A(11)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07019662Not ApplicableRecruiting

Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach

Role: lead

NCT07105930Not ApplicableRecruiting

Trial to Assess Non-inferiority of an Orbital Atherectomy Only Versus a Calcium-tailored Debulking Approach

Role: lead

NCT05324683Active Not Recruiting

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

Role: lead

NCT07215143Not Yet Recruiting

Observational Study to Collect Data of Patient Which Recieving a TAVI in TAVI Procedure

Role: lead

NCT05142124Recruiting

German Cardiac Arrest Registry

Role: collaborator

NCT05717192Not ApplicableRecruiting

BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation

Role: lead

NCT04612179Completed

Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

Role: lead

NCT06742684Not ApplicableWithdrawn

Hyperoxemic Oxygen Therapy in Patients With Acute Anterior Myocardial Infarction

Role: lead

NCT03863132Not ApplicableActive Not Recruiting

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

Role: lead

NCT02433613Completed

Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

Role: collaborator

NCT05786131Not ApplicableRecruiting

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Role: collaborator

NCT03637205Not ApplicableCompleted

Extracorporeal Life Support in Cardiogenic Shock

Role: collaborator

NCT04398654Not ApplicableRecruiting

Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes

Role: lead

NCT05632653Not ApplicableNot Yet Recruiting

CTO-PCI in Heart Failure Patients

Role: collaborator

NCT04240366Not ApplicableRecruiting

Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Role: collaborator

NCT04335188Completed

COVID-19 Registry Rhineland-Palatinate (Germany)

Role: lead

NCT02341534Not ApplicableCompleted

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

Role: collaborator

NCT04611607Completed

Cangrelor in Patients With Acute Myocardial Infarction Undergoing PCI After CPR, Ventilated or Cardiogenic Shock

Role: lead

NCT02066623Completed

Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold

Role: lead

NCT03315650Completed

Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI

Role: lead